Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Imaging (MI), Molecular Therapeutics (MT) and Population Studies and Disparities Research (PSDR).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

The Latest From Karmanos Cancer Institute


Karmanos Cancer Institute and Wayne State University to host two-day symposium focused on advancing health equity and the impact of COVID-19

Karmanos Cancer Institute and Wayne State University will host the virtual event “Community-Engaged Research Symposium to Advance Health Equity: T...

Read More

Karmanos researchers publish article in ‘Nature Reviews Clinical Oncology’

Karmanos Cancer Institute is pleased to announce that the work of Ramzi Mohammad, Ph.D., member, Molecular Therapeutics Research Program, Karmanos...

Read More

Caring for the caregiver

Karmanos Cancer Institute is proud to recognize the month of November as Caregiver Appreciation Month. This time of year naturally provides an opp...

Read More